3D microtumors in vitro supported by perfused vascular networks
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
There is a growing interest in developing microphysiological systems that can be used to model both normal and pathological human organs in vitro. This "organs-on-chips" approach aims to capture key structural and physiological characteristics of the target tissue. Here we describe in vitro vascularized microtumors (VMTs). This "tumor-on-a-chip" platform incorporates human tumor and stromal cells that grow in a 3D extracellular matrix and that depend for survival on nutrient delivery through living, perfused microvessels. Both colorectal and breast cancer cells grow vigorously in the platform and respond to standard-of-care therapies, showing reduced growth and/or regression. Vascular-targeting agents with different mechanisms of action can also be distinguished, and we find that drugs targeting only VEGFRs (Apatinib and Vandetanib) are not effective, whereas drugs that target VEGFRs, PDGFR and Tie2 (Linifanib and Cabozantinib) do regress the vasculature. Tumors in the VMT show strong metabolic heterogeneity when imaged using NADH Fluorescent Lifetime Imaging Microscopy and, compared to their surrounding stroma, many show a higher free/bound NADH ratio consistent with their known preference for aerobic glycolysis. The VMT platform provides a unique model for studying vascularized solid tumors in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumors and stromal cells (endothelial cells) coexisted in these microvessels networks for up to 24 days.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The tumors grew vigorously in the 3D extracellular matrix, depending for survival entirely on nutrient delivery through living, fully functional, and leak-free vasculature.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Remarkably, HCT116-cells growing in the vascularized microfluidic tumors exhibited chemoresistance to oxaliplatin that was one order higher than that shown by cells cultured in a 2D monolayer.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Specifically, this model allows for the creation of “vascularized micro-tumors” (VMTs), whereby the coculture of endothelial colony-forming cell-derived ECs, normal human lung fibroblasts and cancer cells under dynamic flow conditions enables the de novo formation of perfusable microvascular networks that surround the micro-tumors, supplying nutrients and therapeutics just as tumor-associated”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Sobrino et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“The authors recreated, in a geometrically simple device (Figure 7e-i), a fully perfusable and complex vasculature network and was able to demonstrate the feasibility of culturing tumor spheroids for extended time periods.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [58]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sui, X., Kong, N., Wang, X., Fang, Y., Hu, X., Xu, Y., Chen, W., Wang, K., Li, D., Jin, W., et al. (2014) · Scientific Reports · doi:10.1038/srep04694 · Cited by 96
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Cited by
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487
Self-citationOrgan-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
A microfluidic platform integrating functional vascularized organoids-on-chip
Quintard, C., Tubbs, E., Jonsson, G., Jiao, J., Wang, J., Werschler, N., Laporte, C., Pitaval, A., Bah, T.-S., Pomeranz, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45710-4 · Cited by 387
Vascularized cancer on a chip: the effect of perfusion on growth and drug delivery of tumor spheroid
Nashimoto, Y., Okada, R., Hanada, S., Arima, Y., Nishiyama, K., Miura, T., & Yokokawa, R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119547 · Cited by 332
A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications
Phan, D. T. T., Wang, X., Craver, B. M., Sobrino, A., Zhao, D., Chen, J. C., Lee, L. Y. N., George, S. C., Lee, A. P., & Hughes, C. C. W. (2017) · Lab on a Chip · doi:10.1039/c6lc01422d · Cited by 325
Self-citationShirure, V. S., Bi, Y., Curtis, M. B., Lezia, A., Goedegebuure, M. M., Goedegebuure, S. P., Aft, R., Fields, R. C., & George, S. C. (2018) · Lab on a Chip · doi:10.1039/c8lc00596f · Cited by 316
Self-citationOrgan-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
3D bioprinting for reconstituting the cancer microenvironment
Datta, P., Dey, M., Ataie, Z., Unutmaz, D., & Ozbolat, I. T. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0121-2 · Cited by 304
Tumor organoids: applications in cancer modeling and potentials in precision medicine
Xu, H., Jiao, D., Liu, A., & Wu, K. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01278-4 · Cited by 286
Recent advances in microfluidic technologies for cell-to-cell interaction studies
Rothbauer, M., Zirath, H., & Ertl, P. (2018) · Lab on a Chip · doi:10.1039/c7lc00815e · Cited by 277
Wörsdörfer, P., Dalda, N., Kern, A., Krüger, S., Wagner, N., Kwok, C. K., Henke, E., & Ergün, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52204-7 · Cited by 272
Engineering the multiscale complexity of vascular networks
O’Connor, C., Brady, E., Zheng, Y., Moore, E., & Stevens, K. R. (2022) · Nature Reviews Materials · doi:10.1038/s41578-022-00447-8 · Cited by 271
Microfabricated blood vessels for modeling the vascular transport barrier
Polacheck, W. J., Kutys, M. L., Tefft, J. B., & Chen, C. S. (2019) · Nature Protocols · doi:10.1038/s41596-019-0144-8 · Cited by 215
Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment
Tsai, H.-F., Trubelja, A., Shen, A. Q., & Bao, G. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0137 · Cited by 214
Engineering biofunctional in vitro vessel models using a multilayer bioprinting technique
Schöneberg, J., De Lorenzi, F., Theek, B., Blaeser, A., Rommel, D., Kuehne, A. J. C., Kießling, F., & Fischer, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-28715-0 · Cited by 196
Engineering Vascularized Organoid-on-a-Chip Models
Shirure, V. S., Hughes, C. C. W., & George, S. C. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-090120-094330 · Cited by 193
“In this strategy, the microvascular network acquires partial pericyte coverage, a basement membrane, and quiescence prior to the introduction of tumor cells (22, 23).”
BackgroundSelf-citationNeufeld, L., Yeini, E., Reisman, N., Shtilerman, Y., Ben-Shushan, D., Pozzi, S., Madi, A., Tiram, G., Eldar-Boock, A., Ferber, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi9119 · Cited by 189
Jo, Y., Choi, N., Kim, K., Koo, H.-J., Choi, J., & Kim, H. N. (2018) · Theranostics · doi:10.7150/thno.29098 · Cited by 183
“However, the PDX model also has several unresolved limitations such as a time-consuming process and high cost[163].”
BackgroundTrujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
“[48-53] [54-72] Spheroids in microfluidic chambers Spheroids in a hydrogel matrix”
BackgroundAdvances in Engineering Human Tissue Models
Moysidou, C.-M., Barberio, C., & Owens, R. M. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.620962 · Cited by 179
“…heavily on optical transducers, such as fluorescence microscopy, which is more a qualitative assay, that requires labeling (Kim S. et al., 2016; Sobrino et al., 2016), combined with downstream analysis of effluents to detect changes in gene expression and metabolite production (Curto et al.,…”
BackgroundSzklanny, A. A., Machour, M., Redenski, I., Chochola, V., Goldfracht, I., Kaplan, B., Epshtein, M., Simaan Yameen, H., Merdler, U., Feinberg, A., et al. (2021) · Advanced Materials · doi:10.1002/adma.202102661 · Cited by 178
Organs-on-chips technologies – A guide from disease models to opportunities for drug development
Monteduro, A. G., Rizzato, S., Caragnano, G., Trapani, A., Giannelli, G., & Maruccio, G. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115271 · Cited by 175
Advances in On-Chip Vascularization
Haase, K., & Kamm, R. D. (2017) · Regenerative Medicine · doi:10.2217/rme-2016-0152 · Cited by 173
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Nguyen, D.-H. T., Lee, E., Alimperti, S., Norgard, R. J., Wong, A., Lee, J. J.-K., Eyckmans, J., Stanger, B. Z., & Chen, C. S. (2019) · Science Advances · doi:10.1126/sciadv.aav6789 · Cited by 172
Integrated gut/liver microphysiological systems elucidates inflammatory inter‐tissue crosstalk
Chen, W. L. K., Edington, C., Suter, E., Yu, J., Velazquez, J. J., Velazquez, J. G., Shockley, M., Large, E. M., Venkataramanan, R., Hughes, D. J., et al. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26370 · Cited by 172
“systems (MPSs),” employing 3D tissue engineering approaches and often combined with microfluidics to control nutrient and drug distribution and mechanical stimulation (Domansky et al., 2010; Huebsch et al., 2016; Huh et al., 2012; Jeon et al., 2015; Mathur et al., 2015; Roth and Singer, 2014; Sobrino et al., 2016; Sun…”
BackgroundIFlowPlate—A Customized 384‐Well Plate for the Culture of Perfusable Vascularized Colon Organoids
Rajasekar, S., Lin, D. S. Y., Abdul, L., Liu, A., Sotra, A., Zhang, F., & Zhang, B. (2020) · Advanced Materials · doi:10.1002/adma.202002974 · Cited by 164
Advances in hydrogel-based vascularized tissues for tissue repair and drug screening
Wang, Y., Kankala, R. K., Ou, C., Chen, A., & Yang, Z. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.07.005 · Cited by 191
“Moreover, the remarkable progress both in angiogenesis and vasculogenesis is transforming the field of vascular biology and its applications in drug screening [197,198].”
BackgroundMethodA review of microfluidic approaches for investigating cancer extravasation during metastasis
Ma, Y.-H. V., Middleton, K., You, L., & Sun, Y. (2018) · Microsystems & Nanoengineering · doi:10.1038/micronano.2017.104 · Cited by 154
Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
Ayuso, J. M., Truttschel, R., Gong, M. M., Humayun, M., Virumbrales-Munoz, M., Vitek, R., Felder, M., Gillies, S. D., Sondel, P., Wisinski, K. B., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2018.1553477 · Cited by 142
Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering
Osaki, T., Sivathanu, V., & Kamm, R. D. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.03.011 · Cited by 141
Tissue chips – innovative tools for drug development and disease modeling
Low, L. A., & Tagle, D. A. (2017) · Lab on a Chip · doi:10.1039/c7lc00462a · Cited by 140
Hachey, S. J., Movsesyan, S., Nguyen, Q. H., Burton-Sojo, G., Tankazyan, A., Wu, J., Hoang, T., Zhao, D., Wang, S., Hatch, M. M., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc01216e · Cited by 124
Self-citationMimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling
Shukla, P., Yeleswarapu, S., Heinrich, M. A., Prakash, J., & Pati, F. (2022) · Biofabrication · doi:10.1088/1758-5090/ac6d11 · Cited by 148
“…are fabricated with the help of the photolithography technique and used for cancer modeling in static or perfusion-based culture systems to study the progression of different cancers such as lung cancer [74], bladder cancer [75], metastasis model [76], a vascularized cancer-on-chip model [77].”
Applications of tumor chip technology
Hachey, S. J., & Hughes, C. C. W. (2018) · Lab on a Chip · doi:10.1039/c8lc00330k · Cited by 128
Self-citationEndothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model
Haase, K., Offeddu, G. S., Gillrie, M. R., & Kamm, R. D. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002444 · Cited by 127
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
“Microfluidic models that incorporate the microvasculature—either through patterning techniques [73,74] or self-organization of ECs [75,76]—enable study of angiogenesis and intravasation in the BC TME.”
BackgroundMethodInfluentialSelf-citationOrgans-on-chips: Progress, challenges, and future directions
Low, L. A., & Tagle, D. A. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217700523 · Cited by 125
Romero-López, M., Trinh, A. L., Sobrino, A., Hatch, M. M. S., Keating, M. T., Fimbres, C., Lewis, D. E., Gershon, P. D., Botvinick, E. L., Digman, M., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.034 · Cited by 125
“We have previously published on the importance of the 3D microenvironment when studying CRC drug responses [24] and we extend those studies here.”
Self-citationFaal, T., Phan, D. T. T., Davtyan, H., Scarfone, V. M., Varady, E., Blurton-Jones, M., Hughes, C. C. W., & Inlay, M. A. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.005 · Cited by 124
“ECFC-ECs were chosen as the source of ECs because these cells are plastic and robust in adapting to a tissue-specific EC phenotype in the proper native environment (Sobrino et al., 2016; Wang et al., 2016).”
BackgroundSelf-citationAn end-user perspective on Organ-on-a-Chip: Assays and usability aspects
Junaid, A., Mashaghi, A., Hankemeier, T., & Vulto, P. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.02.002 · Cited by 123
Karolak, A. M., Markov, D. A., McCawley, L. J., & Rejniak, K. A. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0703 · Cited by 127
Phan, D. T., Bender, R. H. F., Andrejecsk, J. W., Sobrino, A., Hachey, S. J., George, S. C., & Hughes, C. C. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694100 · Cited by 120
Self-citationLow levels of physiological interstitial flow eliminate morphogen gradients and guide angiogenesis
Shirure, V. S., Lezia, A., Tao, A., Alonzo, L. F., & George, S. C. (2017) · Angiogenesis · doi:10.1007/s10456-017-9559-4 · Cited by 117
Self-citationNeuropathogenesis-on-chips for neurodegenerative diseases
Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 141
“Various hydrogels have been integrated into micro fl uidic chips to demonstrate direct interactions while creating a more physiologically relevant brain tissue-like environment 467,468 .”
MethodXiao, Y., Kim, D., Dura, B., Zhang, K., Yan, R., Li, H., Han, E., Ip, J., Zou, P., Liu, J., et al. (2019) · Advanced Science · doi:10.1002/advs.201801531 · Cited by 115
Microfluidic Tissue Engineering and Bio‐Actuation
Filippi, M., Buchner, T., Yaşa, Ö., Weirich, S., & Katzschmann, R. K. (2022) · Advanced Materials · doi:10.1002/adma.202108427 · Cited by 133
In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed
Bonanini, F., Kurek, D., Previdi, S., Nicolas, A., Hendriks, D., de Ruiter, S., Meyer, M., Clapés Cabrer, M., Dinkelberg, R., García, S. B., et al. (2022) · Angiogenesis · doi:10.1007/s10456-022-09842-9 · Cited by 112
A 3D human renal cell carcinoma-on-a-chip for the study of tumor angiogenesis
Miller, C. P., Tsuchida, C., Zheng, Y., Himmelfarb, J., & Akilesh, S. (2018) · Neoplasia · doi:10.1016/j.neo.2018.02.011 · Cited by 105
Wang, X., Sun, Q., & Pei, J. (2018) · Micromachines · doi:10.3390/mi9100493 · Cited by 106
“developed a 3D microtumor model supported by perfused human microvasculature for anti-cancer drug screening [135].”
MethodSelf-citationIntegrating Organs-on-Chips: Multiplexing, Scaling, Vascularization, and Innervation
Park, D., Lee, J., Chung, J. J., Jung, Y., & Kim, S. H. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.06.006 · Cited by 105
Advances in microfluidic in vitro systems for neurological disease modeling
Holloway, P. M., Willaime‐Morawek, S., Siow, R. C. M., Barber, M., Owens, R. M., Sharma, A. D., Rowan, W. C., Hill, E. J., & Zagnoni, M. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24794 · Cited by 115
“The use of vascularized models has allowed the study of both anti- angiogenic and anti- cancer therapies (Sobrino et al., 2016) as well as in brain- specific models, for instance to assess strategies to enhance drug delivery through the BBB (Bonakdar et al., 2017) and to delineate pathways of brain…”
BackgroundVerhulsel, M., Simon, A., Bernheim-Dennery, M., Gannavarapu, V. R., Gérémie, L., Ferraro, D., Krndija, D., Talini, L., Viovy, J., Vignjevic, D. M., et al. (2020) · Lab on a Chip · doi:10.1039/d0lc00672f · Cited by 111
InVADE: integrated vasculature for assessing dynamic events
Lai, B. F. L., Huyer, L. D., Lu, R. X. Z., Drecun, S., Radisic, M., & Zhang, B. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703524 · Cited by 97
Brown, A., He, H., Trumper, E., Valdez, J., Hammond, P., & Griffith, L. G. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119921 · Cited by 95
Kurokawa, Y. K., Yin, R. T., Shang, M. R., Shirure, V. S., Moya, M. L., & George, S. C. (2017) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2017.0133 · Cited by 91
“11,22,37 The devices were cast of polydimethylsiloxane (PDMS), plasma bonded onto glass slides, and sterilized before cell loading.”
Self-citationPeela, N., Truong, D., Saini, H., Chu, H., Mashaghi, S., Ham, S. L., Singh, S., Tavana, H., Mosadegh, B., & Nikkhah, M. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.017 · Cited by 91
“growth kinetics better mimic in vivo-like conditions for further drug diffusion studies [98].”
BackgroundMicrofluidic-based vascularized microphysiological systems
Lee, S., Ko, J., Park, D., Lee, S.-R., Chung, M., Lee, Y., & Jeon, N. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00285a · Cited by 91
Du, Y., Wang, Y., Bao, Q., Xu, X., Xu, C., Wang, S., Liu, Q., Liu, F., Zeng, Y., Wang, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412815 · Cited by 111
Bioprinting of in vitro tumor models for personalized cancer treatment: a review
Mao, S., Pang, Y., Liu, T., Shao, Y., He, J., Yang, H., Mao, Y., & Sun, W. (2020) · Biofabrication · doi:10.1088/1758-5090/ab97c0 · Cited by 94
“[67] Sobrino A et al 2016 3D microtumors in vitro supported by perfused vascular networks Sci.”
BackgroundZheng, F., Xiao, Y., Liu, H., Fan, Y., & Dao, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000024 · Cited by 107
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 130
Microphysiological Systems: Design, Fabrication, and Applications
Wang, K., Man, K., Liu, J., Liu, Y., Chen, Q., Zhou, Y., & Yang, Y. S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01667 · Cited by 90
3D tumor angiogenesis models: recent advances and challenges
Bhat, S. M., Badiger, V. A., Vasishta, S., Chakraborty, J., Seetharam, P., Ghosh, S., & Joshi, M. B. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03814-0 · Cited by 95
Seo, S., Nah, S.-Y., Lee, K., Choi, N., & Kim, H. N. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106860 · Cited by 94
Intestinal organ chips for disease modelling and personalized medicine
Özkan, A., LoGrande, N., Feitor, J. F., Goyal, G., & Ingber, D. E. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00968-3 · Cited by 109
Zhu, J., Ji, L., Chen, Y., Li, H., Huang, M., Dai, Z., Wang, J., Xiang, D., Fu, G., Lei, Z., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01354-9 · Cited by 93
“A vascularized micro tumors platform was recently reported to test FOLFOX regimen and single agents such as 5-FU, oxaliplatin, and vincristine in three CRC cell lines and endothelial cells, matrix cells, stromal cells [77].”
BackgroundMethodInfluentialDhiman, N., Kingshott, P., Sümer, H., Sharma, C. S., & Rath, S. N. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.02.070 · Cited by 90
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202201784 · Cited by 84
Self-citationIntegrated cancer tissue engineering models for precision medicine
Bregenzer, M. E., Horst, E. N., Mehta, P., Novak, C. M., Raghavan, S., Snyder, C. S., & Mehta, G. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216564 · Cited by 82
Microfluidics for studying metastatic patterns of lung cancer
Ruzycka, M., Cimpan, M. R., Rios-Mondragon, I., & Grudzinski, I. P. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0492-0 · Cited by 82
Lim, J., Ching, H., Yoon, J., Jeon, N. L., & Kim, Y. (2021) · Nano Convergence · doi:10.1186/s40580-021-00261-y · Cited by 91
Weng, K.-C., Kurokawa, Y. K., Hajek, B. S., Paladin, J. A., Shirure, V. S., & George, S. C. (2020) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2019.0248 · Cited by 80
“We and others have presented more complex 3D models of the human microcirculation, including the use of these systems to examine tumor drug sensitivity.(1,7,25) These systems generally involve the creation of 3D vascular networks that form through the process of vasculogenesis or angiogenesis and have the advantage of…”
BackgroundSelf-citationA 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance
Reidy, E., Leonard, N. A., Treacy, O., & Ryan, A. E. (2021) · Cancers · doi:10.3390/cancers13020227 · Cited by 92
Recapitulating the vasculature using ORGAN-ON-CHIP technology
Pollet, A. M. A. O., & den Toonder, J. M. J. (2020) · Bioengineering · doi:10.3390/bioengineering7010017 · Cited by 73
Organ-on-a-Chip Platforms for Drug Screening and Delivery in Tumor Cells: A Systematic Review
Gonçalves, I. M., Carvalho, V. M., Rodrigues, R. O., Pinho, D., Teixeira, S., Moita, A., Hori, T., Kaji, H., Lima, R. A., & Minas, G. M. H. (2022) · Cancers · doi:10.3390/cancers14040935 · Cited by 81
“[43] described a tumor-on-a-chip device that recreates the microenvironment of a tumor, including the vascular system surrounding the cells.”
BackgroundAngiogenic biomaterials to promote therapeutic regeneration and investigate disease progression
Ngo, M. T., & Harley, B. A. C. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120207 · Cited by 78
Pozzi, S., Scomparin, A., Dangoor, S. I., Ajamil, D. R., Ofek, P., Neufeld, L., Krivitsky, A., Vaskovich‐Koubi, D., Kleiner, R., Dey, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.001 · Cited by 79
Emerging tumor-on-chips with electrochemical biosensors
Lei, L., Ma, B., Xu, C., & Liu, H. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116640 · Cited by 72
Advanced technological tools to study multidrug resistance in cancer
Andrei, L., Kasas, S., Ochoa, I., Stanković, T., Korsnes, M. S., Václavíková, R., Assaraf, Y. G., & Pešić, M. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100658 · Cited by 74
Patient-Derived Organoids as a Model for Cancer Drug Discovery
Rae, C., Amato, F., & Braconi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073483 · Cited by 62
“Another microfluidic platform with vascularized microtumours was used to distinguish between drugs which were effective in disrupting vascular networks [94].”
MethodOn-Chip Construction of Liver Lobules with Self-Assembled Perfusable Hepatic Sinusoid Networks
Ya, S., Ding, W., Li, S., Du, K., Zhang, Y., Li, C., Liu, J., Li, F., Li, P., Luo, T., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00794 · Cited by 61
Organoids/organs-on-a-chip: new frontiers of intestinal pathophysiological models
Wu, L., Ai, Y., Xie, R., Xiong, J., Wang, Y., & Liang, Q. (2023) · Lab on a Chip · doi:10.1039/d2lc00804a · Cited by 69
Inspired by Nature: Hydrogels as Versatile Tools for Vascular Engineering
Blache, U., & Ehrbar, M. (2017) · Advances in Wound Care · doi:10.1089/wound.2017.0760 · Cited by 75
“In this regard, vascularized microtumors (VMT) have been generated in hydrogels.(148,149) When such VMT models were connected to perfusion, they allowed for the efficient screening of anti-cancer drugs that affect the microtumors as well as the tumor vasculature (Fig.”
BackgroundLee, S., Kim, S., Koo, D.-J., Yu, J., Cho, H., Lee, H., Song, J. M., Kim, S., Min, D., & Jeon, N. L. (2020) · ACS Nano · doi:10.1021/acsnano.0c05110 · Cited by 68
Engineered Vasculature for Organ-on-a-Chip Systems
Aazmi, A., Zhou, H., Li, Y., Yu, M., Xu, X., Wu, Y., Ma, L., Zhang, B., & Yang, H. (2021) · Engineering · doi:10.1016/j.eng.2021.06.020 · Cited by 69
Kim, D., Hwang, K. S., Seo, E. U., Seo, S., Lee, B. C., Choi, N., Choi, J., & Kim, H. N. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102581 · Cited by 63
Deep Learning for Drug Discovery and Cancer Research: Automated Analysis of Vascularization Images
Urban, G., Bache, K., Phan, D. T. T., Sobrino, A., Shmakov, A. K., Hachey, S. J., Hughes, C. C. W., & Baldi, P. (2019) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2841396 · Cited by 63
“Drug studies were performed in the MPS as previously described [16], [17].”
Self-citationNatividad-Diaz, S. L., Browne, S., Jha, A. K., Ma, Z., Hossainy, S., Kurokawa, Y. K., George, S. C., & Healy, K. E. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.032 · Cited by 67
“The patency of the vessel-like networks was demonstrated by loading HyA-850E into a trichamber microfluidic device intended to create 3D vascular-like fluid flow (Fig 6(a-1,2)) [25, 26, 45].”
MethodSelf-citationBiosynthetic, biomimetic, and self-assembled vascularized Organ-on-a-Chip systems
Fritschen, A., & Blaeser, A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120556 · Cited by 65
3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing
Ahn, J., Kim, D., Koo, D.-J., Lim, J., Park, T., Lee, J., Ko, J., Kim, S., Kim, M., Kang, K., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.10.009 · Cited by 68
In vitro 3D Systems to Model Tumor Angiogenesis and Interactions With Stromal Cells
Brassard-Jollive, N., Monnot, C., Muller, L., & Germain, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.594903 · Cited by 65
“…between tumor– stromal cells and the vasculature (Chung et al., 2017; Miller et al., 2018; Truong et al., 2019); (iii) response to standard therapies (Sobrino et al., 2016); (iv) tumor metabolism, which is an interesting marker for cellular state and response to drugs (Sobrino et al., 2016).”
BackgroundMethodInfluentialRecent Advances in Microfluidic Platforms for Programming Cell‐Based Living Materials
Zhang, P., Shao, N., & Qin, L. (2021) · Advanced Materials · doi:10.1002/adma.202005944 · Cited by 63
Sano, E., Mori, C., Nashimoto, Y., Yokokawa, R., Kotera, H., & Torisawa, Y. (2018) · Biomicrofluidics · doi:10.1063/1.5027183 · Cited by 65
Generation of Vascularized Neural Organoids by Co-culturing with Mesodermal Progenitor Cells
Wörsdörfer, P., Rockel, A., Alt, Y., Kern, A., & Ergün, S. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100041 · Cited by 59
“A possibility to overcome this issue would be the transplantation of these pre-vascularized organoids e.g. into a mouse brain to connect them to the hosts circulation (Cakir et al., 2019) or a connection of the organoid vessels to a microfluidic system (Sobrino et al., 2016).”
BackgroundVascularized Organoids: A More Complete Model
Yu, J. (2020) · International Journal of Stem Cells · doi:10.15283/ijsc20143 · Cited by 59
“Transporting nutrients and the excretion of metabolic wastes should rely on the blood vessels, so it acts as a vital element to maintain the growth of tumors (48).”
Background3D printing for the development of in vitro cancer models
Samavedi, S., & Joy, N. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.06.003 · Cited by 67
Microenvironmental determinants of endothelial cell heterogeneity
Gómez-Salinero, J. M., Redmond, D., & Rafii, S. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00825-w · Cited by 71
Metadata
- Authors
- Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Washington University in St. Louis (US)
- Corresponding author
- Hughes, Christopher C. W.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-23
- Volume
- 6
- Issue
- 1
- Pages
- 31589-31589
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4994029
- OpenAlex
- W2510834891
- Cited by
- 387
- References
- 58
- Citations by year
- 2026: 23 · 2025: 34 · 2024: 41 · 2023: 36 · 2022: 52 · 2021: 56 · 2020: 52 · 2019: 29 · 2018: 35 · 2017: 28 · 2016: 1
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Coordinating Council for Women in History
- National Institutes of Health (UH3TR000481, UL1TR001414, UH2TR000481)
- National Cancer Institute (R01CA170879, P30A062203, R01CA180122)
- National Center for Advancing Translational Sciences
- Chao Family Comprehensive Cancer Center (P30A062203)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumor-on-a-chip, 3D extracellular matrix, colorectal cancer, breast cancer, tumor stroma, vascular targeting agents, VEGFR inhibitors, PDGFR inhibitors, metabolic heterogeneity, aerobic glycolysis, drug response
- MeSH terms
- Breast Neoplasms, Female, Humans, Male, Models, Biological, Neovascularization, Pathologic, Colorectal Neoplasms, Angiogenesis Inhibitors, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.